<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-10-20T14:26:59+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://www.medicinanews.it/cancro-pancreatico-farmaco-rasonque-ema/368892/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-20T13:20:07+02:00</news:publication_date><news:title>Rasonque di Revolution Medicines: il nuovo farmaco per il cancro pancreatico verso l&#8217;approvazione europea</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/conflitti-interesse-fda-advisory-panel/368889/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-20T11:19:09+02:00</news:publication_date><news:title>Conflitti di interesse negli advisory panel FDA: quando i rappresentanti pazienti hanno legami con aziende farmaceutiche</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/sequenziamento-genomico-rapido-diagnosi-neurologica/368886/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-20T09:19:39+02:00</news:publication_date><news:title>Il sequenziamento genomico rapido chiarisce quasi la metà dei casi neurologici pediatrici irrisolti</news:title></news:news></url>
</urlset>
